| Literature DB >> 35740995 |
Bryan Falcones1, Zackarias Söderlund1, Arturo Ibáñez-Fonseca1, Isaac Almendros2, Jordi Otero2, Ramon Farré2, Sara Rolandsson Enes1, Linda Elowsson Rendin1, Gunilla Westergren-Thorsson1.
Abstract
Mesenchymal stromal cell (MSC)-based therapies for inflammatory diseases rely mainly on the paracrine ability to modulate the activity of macrophages. Despite recent advances, there is scarce information regarding changes of the secretome content attributed to physiomimetic cultures and, especially, how secretome content influence on macrophage activity for therapy. hLMSCs from human donors were cultured on devices developed in house that enabled lung-mimetic strain. hLMSC secretome was analyzed for typical cytokines, chemokines and growth factors. RNA was analyzed for the gene expression of CTGF and CYR61. Human monocytes were differentiated to macrophages and assessed for their phagocytic capacity and for M1/M2 subtypes by the analysis of typical cell surface markers in the presence of hLMSC secretome. CTGF and CYR61 displayed a marked reduction when cultured in lung-derived hydrogels (L-Hydrogels). The secretome showed that lung-derived scaffolds had a distinct secretion while there was a large overlap between L-Hydrogel and the conventionally (2D) cultured samples. Additionally, secretome from L-Scaffold showed an HGF increase, while IL-6 and TNF-α decreased in lung-mimetic environments. Similarly, phagocytosis decreased in a lung-mimetic environment. L-Scaffold showed a decrease of M1 population while stretch upregulated M2b subpopulations. In summary, mechanical features of the lung ECM and stretch orchestrate anti-inflammatory and immunosuppressive outcomes of hLMSCs.Entities:
Keywords: MSC-based therapy; lung physiomimetic culture; macrophages; preconditioning
Mesh:
Substances:
Year: 2022 PMID: 35740995 PMCID: PMC9221297 DOI: 10.3390/cells11121866
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1(A) Workflow to achieve physiomimetic culture of hLMSCs with mechanical cues from the lung; (B) 3D images of the physiomimetic culture of hLMSCs. Left side of the image is a 2D representation of the stack captured. In addition, a close-up image is attached showing the cell morphology and dispersion within the biomaterial. (C) Gene expression of CTGF and CYR61 expressed in fold changes compared to the plastic ST group.
Figure 2Secretome profiling of hLMSCs under lung-mimetic signals. (A) Secreted soluble mediators normalized to cell amount of the culture. (B–D) UMAPs representation of hLMSC secretion pointing out proximity of the samples among donors and the microenvironment. (E) Vinyl graphs showed influence of each marker on the whole secretion assayed in the multiplex ELISA. (F) IL6 and TNF-alpha secretion, highlighting the specific effect of CS for each donor.
Figure 3Macrophage activity modulated by the secretome of physiomimetically cultured hLMSCs. (A) Phagocytosis is expressed as % effect compared to the positive control of the assay. * p = 0.0317. (B) Gating strategy to sort the macrophage population and the M2 subpopulations; (C,D) Macrophage subpopulations expressed in fold changes to plastic ST. Bars show mean values for the different conditions assayed: green (plastic), orange (L-Hydrogel) and yellow (L-Scaffold).